Skip to content
YCW15· Other

X-Zell

Early, pain-free cancer detection.

ActiveChecked 19h ago
Batch
W15
Status, per YC
Active
Team size
19
HQ
Bangkok, Thailand
In W15110 companies, 24% AI
x-zell.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About X-Zell

X-ZELL™ is a global start-up specialising in rare cell detection technology. Backed by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC). X-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology. By combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology, X-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making. More information on www.x-zell.com and @XZELLInc

Bangkok, Thailand; Düsseldorf, NRW, Germany

X-Zell: questions

Which YC batch was X-Zell in?

X-Zell was in Y Combinator's Winter 2015 batch (W15).

Is X-Zell still active?

Y Combinator lists X-Zell as active.

Where is X-Zell based?

X-Zell lists Bangkok, Thailand; Düsseldorf, NRW, Germany as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.